Additionally, it is unclear whether SOX9 removal directly converts CCA lesions into HCC fate or simply eliminates CCA tumors during tumor formation, thereby allowing HCC to remain in YAP1-independent cHCC-CCA settings. The gene discussed is YAP1; the disease is hepatocellular carcinoma.